It seems the Windsor Star didn't like my response to their
It seems the Windsor Star didn't like my response to their article yesterday cause it got deleted LieHub style.
"The facility was constructed before Health Canada approved the company for a licence..." Of course the facility was built before. Without a facility there's nothing to inspect hence no license. Also HC did approve the land and zoning that's CEN was given a Ready To Build.
"sold 71 million shares last year, resulting in a personal gain of more than $4.6 million" You later state Mr. Chaban invested $5 million of his own money. Even if you don't believe that he did, why build a $14 million facility and spend more to accelerate the build ? Why not just pocket that money? Why buy another million dollar parcel in the area? Pocket that money too. Why buy a Hemp company? Why make all these moves in Las Vegas, land , apply for license ect ? By the way where do you think this money is coming from? You talk about $4.6 million and so far between the state of the art facility (which no LP can compare to) the second Lakeshore property, Hemp company, Las Vegas , we're talking about five to ten times $4.6 million. Where's the money coming from if not from Mr. Chabaan. Also yes accelerating the build out was HC's idea. Read the timeline that was filed in the court papers--"Letter to Todd Cain Re: Accelerating build out-Built out per request. Letter from HC acknowledging call with Todd Cain"
"It is in the public interest to clarify Health Canada’s actions on this matter.” In whose interest was it to illegally release information about an applicant to the Globe?
"CEN Biotech is alleging in its court documents that Health Canada found only two minor deficiencies, which the company corrected" The Inspection Report was made public back in Aug/Sept. Look it up.
"the property doesn’t have the water, hydro and sewage services that will be needed to support a facility which was touted to annually produce 600,000 kilograms of medical marijuana" The open house done specifically to answer the town's concerns addressed the issue of water. They have a water recycling system that will contain 95% of the water used. Look for the Open house done for the neighbors of Lakeshore it goes more in depth regarding the town's so-called issues.
"Lakeshore council in November also passed a bylaw requiring medical marijuana facilities be located on land zoned for industrial" So after they are welcomed in with open arms and after they have spent $14 million+ on the project Lakeshore changes the law on them. How would you like it if after you spent all your money on a house the town changes zoning on you from residential to industrial. Very underhanded if not illegal to try to apply a brand new law to existing buildings/projects.
"That process of at least six months would involve community feedback and meetings that allow the public to learn about and discuss the plans" Six months ? How long did it take to get this brand new bylaw pushed through ? One month or two ?
"Health Canada issued a statement Friday..." HC practically cut off all communication with the company after inspection in July/Aug. Now after the company demanded the license they felt the deserved on January 29, 2015 HC leaks the Intent to Refuse letter and release another frivolous statement days later. Where was this communication in the previous 7 months.
“Everything they have done so far – even though it might be visually unappealing " Is there any reason to interject that last part in there. Does that sound like someone that is supposed to be an unbiased town official ? Are you starting to see the witch hunt here ?
For an area that has the worst unemployment in Canada and probably all of North America this town doesn't seem to care too much about bringing in jobs for its people. For a town with such high unemployment who is also raising taxes they don't seem to care about a business that would bring in a lot tax revenue if allowed to grow into a billion dollar company as planned. Very interesting to see that apparently/obviously Lakeshore officials' top priority is not the people of Lakeshore. As far as HC and other Canadian government officials they have a lot of explaining to do regarding their relationships with the Globe(leaked Intent to Refuse Letter) and other LPs.
Creative Edge Nutrition Inc. (FITX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Top 5 Most Recently Viewed Articles
Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...
Continue Reading
EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...
Continue Reading
ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...
Continue Reading
Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...
Continue Reading
Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...
Continue Reading